Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trifarotene dose-finding in acne vulgaris
NCT01616654Phase 2Completed
- Sponsor
- Galderma
- Start
- Jun 2012
- Primary completion
- Jul 2013
- Countries
- 1
01
Overview
A Phase 2 trial of CD5789 cream vehicle in acne vulgaris, sponsored by Galderma. Started Jun 2012; status: completed.
02
Drugs
CD5789 cream vehicle
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT01616654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01616654.